ADGM Stock Summary and Trading Ideas (Adagio Medical Holdings | NASDAQ:ADGM)

Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.

Adagio Medical Holdings trades on the NASDAQ stock market under the symbol ADGM.

As of June 18, 2026, ADGM stock price declined to $0.68 with 50,665 million shares trading.

ADGM has a beta of 1.00, meaning it tends to be more sensitive to market movements. ADGM has a correlation of 0.02 to the broad based SPY ETF.

ADGM has a market cap of $15.10 million. This is considered a Sub-Micro Cap stock.

The top ETF exchange traded funds that ADGM belongs to (by Net Assets): VXF, VTI.

ADGM has underperformed the market in the last year with a price return of -37.0% while the SPY ETF gained +26.9%. ADGM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -32.7% and -9.3%, respectively, while the SPY returned +13.5% and -1.1%, respectively.

ADGM support price is $.65 and resistance is $.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADGM shares will trade within this expected range on the day.